An automated controlled-release device for intravaginal hormone delivery

被引:6
作者
Masello, M. [1 ]
Ren, Y. [2 ]
Erickson, D. [2 ]
Giordano, J. O. [1 ]
机构
[1] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA
[2] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA
来源
JDS COMMUNICATIONS | 2020年 / 1卷 / 01期
基金
美国食品与农业研究所;
关键词
DAIRY-COWS; ARTIFICIAL-INSEMINATION; SYNCHRONIZATION; INSTILLATION; POSTPARTUM; OVULATION; ESTRUS; PROSTAGLANDIN-F2-ALPHA; FERTILITY;
D O I
10.3168/jdsc.2020-18816
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Our objective was to develop and validate an electronically controlled hormone-delivery device for reproductive control of cattle. After development and in vitro testing of a prototype device for intravaginal (IVG) hormone release, we aimed to demonstrate the feasibility of inducing luteal regression by automated treatment with PGF 2 alpha . The IVG device comprises an outer 3D-printed plastic housing, fluid reservoirs connected to delivery pumps and tubing, a programmable circuit board, and a retention mechanism. For in vitro testing, 4 pumps were programmed to release different target volumes (0.1, 0.2, 0.5, 1.0, and 2.0 mL) in 4 replicates (n = 80). A Bland-Altman plot was constructed to assess the magnitude of disagreement between expected and delivered volumes. Observations fell within acceptable limits of agreement (1.96 standard deviations) >95% of the time, indicating overall good agreement (mean difference = -0.005 mL). To assess in vivo performance of the IVG device, lactating Holstein cows with at least 1 corpus luteum >= 15 mm in diameter were randomly allocated to 1 of 3 treatments: (1) IM-PGF (n = 6): two 25-mg intramuscular doses of PGF 2 alpha 24 h apart; (2) DEV-PGF (n = 6): four 25-mg doses of PGF 2 alpha released automatically by the IVG device at 10- or 12-h intervals; and (3) DEV-CTL (n = 4): insertion of an empty IVG device (placebo control). Blood samples were collected at 0, 12, 24, 36, 48, and 72 h after treatment. Data were analyzed by ANOVA with repeated measures. All devices (10/10) remained in situ until removed at 48 h. Progesterone (P4) concentrations from 0 to 72 h were affected by treatment, time, and their interaction. Concentrations of P4 did not differ at time 0 but differed from 24 to 72 h: cows in IM-PGF and DEV-PGF had lesser P4 than cows in DEV-CTL. Conversely, P4 did not differ for IM-PGF and DEV-PGF during the experiment. We conclude that the current IVG hormone-releasing device prototype can be programmed to automatically release PGF 2 alpha for successful induction of luteal regression in lactating dairy cows.
引用
收藏
页数:7
相关论文
共 23 条
[21]   Postplacental insertion of the levonorgestrel intrauterine device after cesarean delivery vs. delayed insertion: a randomized controlled trial [J].
Whitaker, Amy K. ;
Endres, Loraine K. ;
Mistretta, Stephanie Q. ;
Gilliam, Melissa L. .
CONTRACEPTION, 2014, 89 (06) :534-539
[22]   Vaginitis incidence and effects on fertility of beef females enrolled on estrus synchronization protocols using a controlled internal drug release (CIDR) device [J].
Dias, Nicholas W. ;
Sales, Alvaro ;
Timlin, Claire ;
Pancini, Stefania ;
Currin, John ;
Mercadante, Vitor R. G. .
JOURNAL OF ANIMAL SCIENCE, 2019, 97 :242-242
[23]   Effectiveness of melatonin and controlled internal drug release device treatment on reproductive performance of buffalo heifers during out-of-breeding season under tropical conditions [J].
Ramadan, T. A. ;
Sharma, R. K. ;
Phulia, S. K. ;
Balhara, A. K. ;
Ghuman, S. S. ;
Singh, I. .
THERIOGENOLOGY, 2014, 82 (09) :1296-1302